Prevalence of HTLV-III/LAV Antibodies among Haitians

Arthur E. Pitchenik; Thomas J. Spira; Robert Elie; Margaret A. Fischl; Jane P. Getchell; Emmanuel Arnoux; Gerard D. Pierre; A. Claude Laroche; Jean Michel Guerin; Rodolphe Malebranche

doi:10.1056/NEJM198506273122609

Prevalence of HTLV-III/LAV Antibodies among Haitians

Arthur E. Pitchenik, Thomas J. Spira, Robert Elie, Margaret A. Fischl, Jane P. Getchell, Emmanuel Arnoux, Gerard D. Pierre, A. Claude Laroche, Jean Michel Guerin, Rodolphe Malebranche

Medicine

Research output: Contribution to journal › Letter

5 Scopus citations

Abstract

To the Editor: The prevalence of antibodies to the human T-cell lymphotropic virus Type III/lymphadenopathy-associated virus (HTLV-III/LAV) has been reported in various groups at increased risk for the acquired immunodeficiency syndrome (AIDS)¹: 22 to 65 per cent in homosexual men, 87 per cent in intravenous drug abusers admitted to a detoxification program in New York City, and 56 to 72 per cent in persons with hemophilia A. Although persons born in Haiti have been considered to be at increased risk for AIDS, the prevalence of antibodies to HTLV-III/LAV has not been reported among randomly selected Haitian populations living in.

Original language	English (US)
Pages (from-to)	1705-1706
Number of pages	2
Journal	New England Journal of Medicine
Volume	312
Issue number	26
DOIs	https://doi.org/10.1056/NEJM198506273122609
State	Published - Jun 27 1985

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1056/NEJM198506273122609

Fingerprint Dive into the research topics of 'Prevalence of HTLV-III/LAV Antibodies among Haitians'. Together they form a unique fingerprint.

Cite this

Pitchenik, A. E., Spira, T. J., Elie, R., Fischl, M. A., Getchell, J. P., Arnoux, E., Pierre, G. D., Laroche, A. C., Guerin, J. M., & Malebranche, R. (1985). Prevalence of HTLV-III/LAV Antibodies among Haitians. New England Journal of Medicine, 312(26), 1705-1706. https://doi.org/10.1056/NEJM198506273122609

Prevalence of HTLV-III/LAV Antibodies among Haitians. / Pitchenik, Arthur E.; Spira, Thomas J.; Elie, Robert; Fischl, Margaret A.; Getchell, Jane P.; Arnoux, Emmanuel; Pierre, Gerard D.; Laroche, A. Claude; Guerin, Jean Michel; Malebranche, Rodolphe.

In: New England Journal of Medicine, Vol. 312, No. 26, 27.06.1985, p. 1705-1706.

Research output: Contribution to journal › Letter

@article{552b2ea30f884211bd82ab074342f6ac,

title = "Prevalence of HTLV-III/LAV Antibodies among Haitians",

abstract = "To the Editor: The prevalence of antibodies to the human T-cell lymphotropic virus Type III/lymphadenopathy-associated virus (HTLV-III/LAV) has been reported in various groups at increased risk for the acquired immunodeficiency syndrome (AIDS)1: 22 to 65 per cent in homosexual men, 87 per cent in intravenous drug abusers admitted to a detoxification program in New York City, and 56 to 72 per cent in persons with hemophilia A. Although persons born in Haiti have been considered to be at increased risk for AIDS, the prevalence of antibodies to HTLV-III/LAV has not been reported among randomly selected Haitian populations living in.",

author = "Pitchenik, {Arthur E.} and Spira, {Thomas J.} and Robert Elie and Fischl, {Margaret A.} and Getchell, {Jane P.} and Emmanuel Arnoux and Pierre, {Gerard D.} and Laroche, {A. Claude} and Guerin, {Jean Michel} and Rodolphe Malebranche",

year = "1985",

month = jun,

day = "27",

doi = "10.1056/NEJM198506273122609",

language = "English (US)",

volume = "312",

pages = "1705--1706",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "26",

}

TY - JOUR

T1 - Prevalence of HTLV-III/LAV Antibodies among Haitians

AU - Pitchenik, Arthur E.

AU - Spira, Thomas J.

AU - Elie, Robert

AU - Fischl, Margaret A.

AU - Getchell, Jane P.

AU - Arnoux, Emmanuel

AU - Pierre, Gerard D.

AU - Laroche, A. Claude

AU - Guerin, Jean Michel

AU - Malebranche, Rodolphe

PY - 1985/6/27

Y1 - 1985/6/27

N2 - To the Editor: The prevalence of antibodies to the human T-cell lymphotropic virus Type III/lymphadenopathy-associated virus (HTLV-III/LAV) has been reported in various groups at increased risk for the acquired immunodeficiency syndrome (AIDS)1: 22 to 65 per cent in homosexual men, 87 per cent in intravenous drug abusers admitted to a detoxification program in New York City, and 56 to 72 per cent in persons with hemophilia A. Although persons born in Haiti have been considered to be at increased risk for AIDS, the prevalence of antibodies to HTLV-III/LAV has not been reported among randomly selected Haitian populations living in.

AB - To the Editor: The prevalence of antibodies to the human T-cell lymphotropic virus Type III/lymphadenopathy-associated virus (HTLV-III/LAV) has been reported in various groups at increased risk for the acquired immunodeficiency syndrome (AIDS)1: 22 to 65 per cent in homosexual men, 87 per cent in intravenous drug abusers admitted to a detoxification program in New York City, and 56 to 72 per cent in persons with hemophilia A. Although persons born in Haiti have been considered to be at increased risk for AIDS, the prevalence of antibodies to HTLV-III/LAV has not been reported among randomly selected Haitian populations living in.

UR - http://www.scopus.com/inward/record.url?scp=0021823838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021823838&partnerID=8YFLogxK

U2 - 10.1056/NEJM198506273122609

DO - 10.1056/NEJM198506273122609

M3 - Letter

C2 - 3858670

AN - SCOPUS:0021823838

VL - 312

SP - 1705

EP - 1706

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 26

ER -